Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease-Reference-Cited by-同舟云学术

Acceptable performance of blood biomarker tests of amyloid pathology — recommendations from the Global CEO Initiative on Alzheimer’s Disease

Published:2024-06-12 Issue:7 Volume:20 Page:426-439
ISSN:1759-4758
Container-title:Nature Reviews Neurology
language:en
Short-container-title:Nat Rev Neurol

Author:

Schindler Suzanne E.^ORCID,Galasko Douglas,Pereira Ana C.,Rabinovici Gil D.,Salloway Stephen,Suárez-Calvet Marc^ORCID,Khachaturian Ara S.^ORCID,Mielke Michelle M.^ORCID,Udeh-Momoh Chi,Weiss Joan,Batrla Richard,Bozeat Sasha,Dwyer John R.,Holzapfel Drew,Jones Daryl Rhys,Murray James F.,Partrick Katherine A.,Scholler Emily,Vradenburg George,Young Dylan,Algeciras-Schimnich Alicia,Aubrecht Jiri,Braunstein Joel B.,Hendrix James,Hu Yan Helen^ORCID,Mattke Soeren^ORCID,Monane Mark,Reilly David,Somers Elizabeth,Teunissen Charlotte E.,Shobin Eli,Vanderstichele Hugo,Weiner Michael W.,Wilson David,Hansson Oskar^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41582-024-00977-5.pdf

Reference111 articles.

1. Engelborghs, S. et al. Diagnostic performance of a CSF-biomarker panel in autopsy-confirmed dementia. Neurobiol. Aging 29, 1143–1159 (2008).

2. Hampel, H. et al. Blood-based biomarkers for Alzheimer’s disease: current state and future use in a transformed global healthcare landscape. Neuron 111, 2781–2799 (2023).

3. Schindler, S. E. & Atri, A. The role of cerebrospinal fluid and other biomarker modalities in the Alzheimer’s disease diagnostic revolution. Nat. Aging 3, 460–462 (2023).

4. Hansson, O. et al. The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease. Alzheimers Dement. 18, 2669–2686 (2022).

5. Hansson, O., Blennow, K., Zetterberg, H. & Dage, J. Blood biomarkers for Alzheimer’s disease in clinical practice and trials. Nat. Aging 3, 506–519 (2023).

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic value of Alzheimer's disease plasma biomarkers in the oldest-old: a prospective primary care-based study;The Lancet Regional Health - Europe;2024-10

2. A Decade of Protecting Progress: Ethics Review;Journal of Alzheimer's Disease;2024-08-20

3. CAPS: a simple clinical tool for β-amyloid positivity prediction in clinical Alzheimer syndrome;Frontiers in Neurology;2024-08-14

4. Clinical Assessment of a Plasma AT(N) Panel for Alzheimer’s Disease;2024-08-08

5. Blood-Based Biomarkers for Alzheimer Disease—Ready for Primary Care?;JAMA Neurology;2024-07-28